Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Advisory Committee Reboot (Part I): Open Public Meeting A Place To Start?

Executive Summary

CDER Director Patrizia Cavazzoni raised eyebrows when she stated an intent to remove the ‘emotional overtone’ of committee meetings. The open public hearing may be a place to start.

You may also be interested in...



US FDA Advisory Committee Members Say Votes Should More Directly Affect Agency Decisions

Survey of advisory committee members finds many believe an overwhelmingly negative vote should prevent a product approval. Survey was prompted by FDA accelerated approval of Alzheimer’s disease treatment Aduhelm despite overwhelming committee rejection.

Power To The (Adcomm) People: Members Believe Votes Should More Directly Affect US FDA Decisions

A survey of advisory committee members finds many believe that an overwhelmingly negative vote should prevent a product approval.

US FDA Advisory Committee Reboot (Part III): Asking The Right Questions

Rethinking the voting and discussion questions to advisory committees may be one way to ensure FDA gets the advice it needs.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS144549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel